ArticleCells2022

Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer.

Davide Vecchiotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.